C
RELX PLC RELX
$33.82 -$0.04-0.12% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

RELX PLC is a global provider of information-based analytics and decision tools serving professional and business customers across multiple industries. The company operates primarily in the scientific, technical, and medical (STM), legal, risk, and exhibitions sectors, delivering data, analytics, and workflow solutions that support critical decision-making. RELX generates the majority of its revenue from subscription-based and recurring services, particularly in analytics-driven products, which provides revenue stability and high margins.

RELX’s primary business lines include RELX Scientific, Technical & Medical, RELX Legal, RELX Risk, and RELX Exhibitions. Its products are widely used by researchers, healthcare professionals, lawyers, compliance officers, insurers, and corporations. The company is known for its strong intellectual property assets, extensive proprietary databases, and advanced analytics capabilities, including artificial intelligence and machine learning. RELX traces its origins to the late 19th century as a traditional publishing business and evolved through strategic divestments and acquisitions into a technology- and analytics-focused enterprise, notably following the rebranding from Reed Elsevier to RELX in 2015.

Business Operations

RELX operates through four major segments. RELX Scientific, Technical & Medical provides digital platforms, journals, and data solutions to researchers and healthcare institutions, with products such as ScienceDirect and Scopus forming core revenue drivers. RELX Legal, primarily through LexisNexis Legal & Professional, delivers legal research, news, and workflow solutions to law firms, corporations, and governments. RELX Risk, operating largely under LexisNexis Risk Solutions, supplies data analytics and decision tools for fraud prevention, credit risk, insurance underwriting, and identity verification. RELX Exhibitions organizes large-scale, face-to-face and digital events, serving industries such as energy, construction, and technology.

The company operates both domestically and internationally, with a significant portion of revenue generated outside its home markets. RELX controls extensive proprietary datasets, digital platforms, and analytics technologies, including AI-driven risk scoring and research tools. Key subsidiaries include Elsevier, LexisNexis, LexisNexis Risk Solutions, and RX Global (the exhibitions business). RELX also maintains technology partnerships and data integrations with institutional customers, governments, and enterprise clients worldwide.

Strategic Position & Investments

RELX’s strategy centers on accelerating growth in analytics, decision tools, and data-driven services while maintaining high recurring revenue and strong cash generation. The company continues to invest in artificial intelligence, machine learning, and cloud-based platforms to enhance product capabilities across all segments. Growth initiatives emphasize expanding risk and fraud analytics, improving workflow automation in legal and research markets, and increasing digital engagement within exhibitions.

RELX has a long history of targeted acquisitions to strengthen data assets and analytics capabilities, particularly within LexisNexis Risk Solutions, which has acquired multiple niche data and identity verification companies over time. The company selectively divests non-core or lower-growth assets to focus on higher-margin analytics businesses. Emerging areas of investment include predictive analytics, responsible AI, and tools supporting regulatory compliance, public safety, and healthcare research.

Geographic Footprint

RELX is headquartered in London, United Kingdom, with a dual-listed structure in the UK and the Netherlands. The company has a substantial operational presence in North America, which represents its largest revenue-generating region, particularly for legal and risk analytics businesses. It also maintains strong market positions across Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

RELX’s global footprint includes offices, data centers, and research hubs across more than 40 countries. Its international influence is reinforced through long-term contracts with multinational corporations, academic institutions, and government agencies, as well as through global exhibitions hosted under RX Global. The company continues to expand internationally by localizing data assets and analytics solutions to meet regional regulatory and market needs.

Leadership & Governance

RELX follows a governance model emphasizing long-term value creation, disciplined capital allocation, and ethical use of data and analytics. The company’s leadership focuses on sustainable growth, technological innovation, and maintaining high standards of data privacy and compliance across jurisdictions. RELX’s board and executive management have extensive experience in global information services, technology, and regulated industries.

Key executives include:

  • Erik Engstrom – Chief Executive Officer
  • Nick Luff – Chief Financial Officer
  • Anne Leven – Chief Operating Officer
  • Mark Kelsey – Chief Executive Officer, LexisNexis Legal & Professional
  • Haywood Talcove – Chief Executive Officer, LexisNexis Risk Solutions

The leadership team promotes a strategy centered on analytics-led growth, responsible innovation, and consistent returns to shareholders through dividends and share buybacks, aligned with the company’s long-term strategic vision.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $178.56
B
AAPL NASDAQ $248.96
B
MSFT NASDAQ $389.02
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $120.84
B
Top Financial Stocks
See All »
B
B
JPM NYSE $287.97
B
V NYSE $299.71
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.07
Top Health Care Stocks
See All »
B
LLY NYSE $917.50
B
JNJ NYSE $237.60
B
AMGN NASDAQ $349.92
Top Real Estate Stocks
See All »
B
PLD NYSE $131.09